ViiV Healthcare secures Juluca FDA approval for virologically suppressed HIV-1
Juluca FDA approval : ViiV Healthcare’s 2-drug regimen Juluca has secured approval from the US Food and Drug Administration (FDA)
Continue readingCoverage of Global Pharma Industry News
Juluca FDA approval : ViiV Healthcare’s 2-drug regimen Juluca has secured approval from the US Food and Drug Administration (FDA)
Continue readingAcalabrutinib FDA approval : AstraZeneca has secured an early approval for its blood cancer drug Calquence (acalabrutinib) for the treatment
Continue reading